A Randomised Multicentre Open Label, Blinded End Point Trial to Compare the Effects of Spironolactone to Chlortalidone on Left Ventricular Mass and Arterial Stiffness in Stage 2 & 3 Chronic Kidney Disease (SPIRO-CKD)

Short title	A Randomised Multicentre Open Label, Blinded End Point Trial to Compare the Effects of Spironolactone to Chlortalidone on Left Ventricular Mass and Arterial Stiffness in Stage 2 & 3 Chronic Kidney Disease (SPIRO-CKD)
Status	Finished
Effective start/end date	1/03/14 → 28/02/18

Project Details